Literature DB >> 1445287

The matrix-degrading metalloproteinases.

L M Matrisian1.   

Abstract

The matrix-degrading metalloproteinases are an intriguing family of enzymes that have evolved to digest specific extracellular matrix components. The expression of these enzymes is very highly regulated and can be controlled transcriptionally by a number of growth factors, tumor promoters, oncogenes, and hormones. It is suggested that the coordinated regulation of matrix metalloproteinases and their inhibitors by these agents modify the integrity of the extracellular matrix. These modifications may, at least in part, be responsible for mediating the effects of these factors on complex physiological processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445287     DOI: 10.1002/bies.950140705

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  252 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.

Authors:  A Stallmach; C C Chan; K W Ecker; G Feifel; H Herbst; D Schuppan; M Zeitz
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

3.  Characterization, expression analysis and chromosomal mapping of mouse matrix metalloproteinase-19 (MMP-19).

Authors:  J J Caterina; J Shi; C A Kozak; J A Engler; H Birkedal-Hansen
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

4.  Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.

Authors:  Pallavi Garg; Matam Vijay-Kumar; Lixin Wang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02       Impact factor: 4.052

5.  Front instabilities and invasiveness of simulated avascular tumors.

Authors:  Nikodem J Popławski; Ubirajara Agero; J Scott Gens; Maciej Swat; James A Glazier; Alexander R A Anderson
Journal:  Bull Math Biol       Date:  2009-02-21       Impact factor: 1.758

6.  Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.

Authors:  Nicholas A Dewyer; Vikram Sood; Erin M Lynch; Catherine E Luke; Gilbert R Upchurch; Thomas W Wakefield; Steven Kunkel; Peter K Henke
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

7.  Anomalous pH-dependence of the activity of human matrilysin (matrix metalloproteinase-7) as revealed by nitration and amination of its tyrosine residues.

Authors:  Yuko Muta; Hiroshi Oneda; Kuniyo Inouye
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 8.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Matrix metalloproteinase-9-null mice are resistant to TGF-β-induced anterior subcapsular cataract formation.

Authors:  Anna Korol; Giuseppe Pino; Dhruva Dwivedi; Jennifer V Robertson; Paula A Deschamps; Judith A West-Mays
Journal:  Am J Pathol       Date:  2014-05-06       Impact factor: 4.307

10.  Real-time imaging of the axonal transport of granules containing a tissue plasminogen activator/green fluorescent protein hybrid.

Authors:  J E Lochner; M Kingma; S Kuhn; C D Meliza; B Cutler; B A Scalettar
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.